novartis ceo vas narasimhan on the latest research on a breast cancer drug
Published 1 year ago • 6.6K plays • Length 3:43Download video MP4
Download video MP3
Similar videos
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
24:07
novartis ceo vas narasimhan on the david rubenstein show
-
4:22
novartis ceo on new cancer therapy programs
-
3:58
meet our people: vas narasimhan
-
43:50
vasant narasimhan, chief executive officer, novartis | bsr18
-
9:32
vasant narasimhan novartis ceo on transforming pharma industry
-
2:50
new research shows how to lower your risk for cancer
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
3:01
novartis ceo vas narasimhan: strategic approach to weight-loss drug development | n18v | cnbc tv18
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
6:12
novartis ceo: expect continued growth in 2023
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
2:50
new research into ways to lower your cancer risk
-
6:15
coronavirus: novartis ceo vas narasimhan on the timeline for coronavirus treatments
-
21:49
novartis ceo narasimhan on covid, treatments
-
3:29
innovative medicines business returning to growth, novartis ceo says
-
0:58
novartis ceo vas narasimhan on covid-19 antibodies
-
14:58
weight-loss drug ozempic a 'medical breakthrough', but we won't be driven by fomo: novartis ceo
-
9:48
novartis ceo: growth drivers performing well, but product exclusivity losses creating headwinds
-
11:50
novartis ‘focusing on high-end, innovative medicines,’ ceo says